Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio2.unb.br/jspui/handle/10482/44883
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_OverviewImmunogenicCell.pdf1,79 MBAdobe PDFVisualizar/Abrir
Título: An overview on immunogenic cell death in cancer biology and therapy
Autor(es): Rodrigues, Mosar Corrêa
Morais, José Athayde Vasconcelos
Ganassin, Rayane
Oliveira, Giulia Rosa Tavares
Costa, Fabiana Chagas
Morais, Amanda Alencar Cabral
Silveira, Ariane Pandolfo
Silva, Victor Carlos Mello
Longo, João Paulo Figueiró
Muehlmann, Luis Alexandre
E-mail do autor: mailto:mosarcr@gmail.com
mailto:joseavmorais@gmail.com
mailto:rayaneganassin@hotmail.com
mailto:giulia_rosa12@hotmail.com
mailto:fchagas16@gmail.com
mailto:amandaalencarcabral@gmail.com
mailto:pandolfo.ariane@gmail.com
mailto:victor@spctm.com
mailto:jplongo82@gmail.com
mailto:luisalex@unb.br
ORCID: https://orcid.org/0000-0003-3067-4842
https://orcid.org/0000-0002-6974-0889
https://orcid.org/0000-0002-5154-7263
Assunto: Morte celular imunogênica
Câncer - tratamento
Sistema imunológico
Data de publicação: 27-Jul-2022
Editora: MDPI
Referência: RODRIGUES, Mosar Corrêa et al. An overview on immunogenic cell death in cancer biology and therapy. Pharmaceutics, Basel, v. 14, n. 8, art. 1564, jul. 2022. DOI 10.3390/pharmaceutics14081564. Disponível em: https://www.mdpi.com/1999-4923/14/8/1564. Acesso em: 23 set. 2022.
Abstract: Immunogenic cell death (ICD) is a modality of regulated cell death that is sufficient to promote an adaptive immune response against antigens of the dying cell in an immunocompetent host. An important characteristic of ICD is the release and exposure of damage-associated molecular patterns, which are potent endogenous immune adjuvants. As the induction of ICD can be achieved with conventional cytotoxic agents, it represents a potential approach for the immunotherapy of cancer. Here, different aspects of ICD in cancer biology and treatment are reviewed.
Licença: Pharmaceutics - Articles published in Sustainability will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2022 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). Fonte: https://www.mdpi.com/journal/pharmaceutics/about. Acesso em: 23 set. 2022.
DOI: https://doi.org/10.3390/pharmaceutics14081564
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro completo do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.